ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

INMB INmune Bio Inc

11.29
0.45 (4.15%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
INmune Bio Inc INMB 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.45 4.15% 11.29 09:00:00
개장가 저가 고가 종가 전일 종가
10.83 10.83 11.73 11.29 10.84
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
25/04/202422:00GLOBEINmune Bio Inc. Announces $9.7 Million Registered Direct..
23/04/202421:00GLOBEINmune Bio Inc. Announces 24-Month Stability Validation of..
22/04/202421:00GLOBEINmune Bio Inc. Raises Approximately $4.8 Million in Gross..
08/04/202421:00GLOBEINmune Bio Inc. Presents Data on INB03’s Role as an Immune..
29/03/202405:01GLOBEINmune Bio Inc. Announces Year End 2023 Results and Provides..
27/03/202405:01GLOBEINmune Bio Inc. to Report Fourth Quarter 2023 Financial..
13/03/202421:00GLOBEINmune Bio CSO and Co-Founder Mark Lowdell, Ph.D. Receives..
05/03/202422:00GLOBEINmune Bio Reports Significant EEG Improvement in..
12/02/202423:00GLOBEINmune Bio to Participate in the Oppenheimer 34th Annual..
06/02/202423:00GLOBEINmune Bio to Participate in Baird’s Biotech Discovery..
30/01/202422:02EDGAR2Form 8-K - Current report
30/01/202422:00GLOBEINmune Bio Announces FDA Removal of Clinical Hold for..
16/01/202422:30GLOBEELEVAI Labs, Inc. Acquires Worldwide License Agreement for..
03/01/202406:00EDGAR2Form 8-K - Current report
02/01/202422:00GLOBEINmune Bio Announces First Patient Dosed in a Phase 1/2..
19/12/202306:15EDGAR2Form 8-K - Current report
19/12/202306:05EDGAR2Form 8-A12B/A - Registration of securities [Section 12(b)]:..
19/12/202306:01EDGAR2Form 8-K - Current report
19/12/202306:01GLOBEINmune Bio Provides Update Regarding Global Alzheimer’s..
30/11/202306:00EDGAR2Form 8-K - Current report
29/11/202322:00GLOBEINmune Bio Inc. Demonstrates that INB03 Enhances the Uptake..
28/11/202306:00EDGAR2Form 8-K - Current report
27/11/202322:00GLOBEINmune Bio Receives EMA’s Authorization in France and Spain..
16/11/202306:13EDGAR2Form 8-K - Current report
15/11/202323:00GLOBEINmune Bio Inc. Announces Expansion of Phase II Clinical..
14/11/202301:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202305:13EDGAR2Form 8-K - Current report
02/11/202305:10GLOBEINmune Bio Inc. Announces Third Quarter 2023 Results and..
02/11/202305:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202305:25EDGAR2Form 8-K - Current report
31/10/202321:00GLOBEINmune Bio Inc. Patent Claims Covering INB16 Cell Line and..
30/10/202322:07GLOBEINmune Bio Inc. Presents Preclinical Data at SITC 2023..
17/10/202321:00GLOBEINmune Bio Inc. Presents New Biomarker and Feasibility Data..
16/10/202322:00GLOBEINmune Bio Inc. to Report Third Quarter 2023 Financial..
07/09/202322:10EDGAR2Form 8-K - Current report
07/09/202322:00GLOBEINmune Bio Inc. to Present at Baird Global Healthcare..
06/09/202305:00EDGAR2Form 8-K - Current report
05/09/202321:00GLOBEINmune Bio Inc. Announces Approval of Clinical Trial..
17/08/202305:41EDGAR2Form 8-K - Current report
17/08/202305:39EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/08/202305:01EDGAR2Form 8-K - Current report
08/08/202305:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/08/202305:00GLOBEINmune Bio Inc. Announces Second Quarter 2023 Results and..
02/08/202319:02EDGAR2Form 8-K - Current report
01/08/202321:00GLOBEINmune Bio Inc. to Present at the BTIG Virtual ..
31/07/202321:00GLOBEINmune Bio, Inc. to Report Second Quarter 2023 Financial..
28/07/202305:43EDGAR2Form 8-K - Current report
15/07/202305:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/07/202305:00EDGAR2Form 8-K - Current report
13/07/202302:23EDGAR2Form 144 - Report of proposed sale of securities

최근 히스토리

Delayed Upgrade Clock